SCHEMBL424237

SCHEMBL424237

Cc1ccc(-c2cn(C(=O)N(C)C3CCCCC3)cn2)cc1NS(C)(=O)=O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 1/20 0.56
CES2 O00748 1/20 0.56
BACE1 P56817 5/20 0.40
BRD4 O60885 2/20 0.38
CREBBP Q92793 2/20 0.38
CECR2 Q9BXF3 2/20 0.38
BRD9 Q9H8M2 2/20 0.38
TRIM24 O15164 1/20 0.38
BRD1 O95696 1/20 0.38
TAF1 P21675 1/20 0.38
BRD2 P25440 1/20 0.38
SMARCA4 P51532 1/20 0.38
BRPF1 P55201 1/20 0.38
BPTF Q12830 1/20 0.38
BRDT Q58F21 1/20 0.38
ATAD2 Q6PL18 1/20 0.38
PBRM1 Q86U86 1/20 0.38
TAF1L Q8IZX4 1/20 0.38
KAT2B Q92831 1/20 0.38
BRD7 Q9NPI1 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL426110 0.88 FAAH (0.54) FAAHCES2BACE1BRD4KDM4E
SCHEMBL426580 0.82 FAAH (0.59) FAAHCES2BACE1CNR2NPC1
SCHEMBL426096 0.81 FAAH (0.67) FAAHCES2ALDH1A1POLB
SCHEMBL14950289 0.81 FAAH (0.66) FAAHCES2NPC1RAB9APOLB
SCHEMBL424238 0.80 FAAH (0.60) FAAHCES2KDM4ERAB9APOLB
SCHEMBL14950186 0.80 FAAH (0.64) FAAHCES2NPC1RAB9APOLB
SCHEMBL425914 0.79 FAAH (0.66) FAAHCES2NPC1ALDH1A1RAB9A
SCHEMBL426004 0.79 FAAH (0.66) FAAHCES2ALDH1A1POLBS1PR1
SCHEMBL7890274 0.79 FAAH (0.58) FAAHCES2MAPK14
SCHEMBL425460 0.78 FAAH (0.58) FAAHCES2NPC1ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9353082-B2 Pharmaceutical compounds BIAL—PORTELA & CA, S.A. (PT) 2016-05-31 US disclosed
US-20120065191-A1 PHARMACEUTICAL COMPOUNDS BIAL - PORTELA & Cª, S.A. (PT) 2012-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120065191-A1 PHARMACEUTICAL COMPOUNDS FAAH, FAAH2, ASAH1 FAAH 1/4885CES2 62/4885BACE1 480/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.